SCHEMBL3719792

SCHEMBL3719792

CC(CC(=O)O)(C(=O)O)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.64
HIF1A Q16665 2/20 0.64
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
CYP1A2 P05177 3/20 0.43
CYP2D6 P10635 2/20 0.43
TSHR P16473 2/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
ALDH1A1 P00352 3/20 0.40
SLC13A5 Q86YT5 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11138820 0.91 CYP2C19 (0.52) CYP2C19HIF1AKMT2ACYP1A2CYP2D6
SCHEMBL28435577 0.89 HIF1A (0.52) CYP2C19HIF1AMAPTKMT2ACYP1A2
SCHEMBL31172766 0.84 CYP2C19 (0.60) CYP2C19HIF1AMAPTKMT2ACYP1A2
SCHEMBL10972965 0.82 CYP2C19 (0.44) CYP2C19HIF1AMAPTKMT2ACYP2D6
SCHEMBL27484429 0.82 HIF1A (0.48) CYP2C19HIF1AMAPTKMT2ACYP1A2
SCHEMBL10982127 0.82 KCNN4 (0.58) CYP2C19HIF1AMAPTKMT2ATSHR
SCHEMBL4949586 0.82 CYP2C19 (0.48) CYP2C19HIF1AMAPTKMT2ACYP1A2
SCHEMBL4870717 0.82 CYP2C19 (0.61) CYP2C19HIF1AMAPTKMT2ACYP1A2
SCHEMBL21119499 0.81 CYP2C19 (0.56) CYP2C19HIF1AMAPTKMT2ACYP1A2
SCHEMBL21119500 0.81 CYP2C19 (0.56) CYP2C19HIF1AMAPTKMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117567225-A Method for preparing dicarboxylic acid compound from olefin 徐州医科大学 2024-02-20 CN disclosed
US-10947231-B2 Processes for the preparation of substituted tetrahydro beta-carbolines PTC THERAPEUTICS, INC. (US) 2021-03-16 US disclosed
CN-110028403-B Method for synthesizing succinic acid compound 四川大学 2020-08-11 CN disclosed
CN-110028403-A A kind of method of synthesizing succinic acid class compound 四川大学 2019-07-19 CN disclosed
US-20190135810-A1 PROCESSES FOR THE PREPARATION OF SUBSTITUTED TETRAHYDRO BETA-CARBOLINES PTC THERAPEUTICS INC (US) 2019-05-09 US disclosed
US-20120136154-A1 PROCESSES FOR THE PREPARATION OF SUBSTITUTED TETRAHYDRO BETA-CARBOLINES PTC THERAPEUTICS, INC. 2012-05-31 US disclosed
CN-102459263-A Process for the preparation of substituted tetrahydro beta-carbolines PTC THERAPEUTICS INC 2012-05-16 CN disclosed
WO-2010138644-A1 PROCESSES FOR THE PREPARATION OF SUBSTITUTED TETRAHYDRO BETA-CARBOLINES PTC THERAPEUTICS, INC. (US) 2010-12-02 WO disclosed
EP-1268581-B1 STABLE INITIATOR SYSTEM JOHNSON & JOHNSON VISION CARE (US) 2004-11-24 EP disclosed
US-6720079-B2 THERMOSETTING POWDER COMPOSITION INCLUDING EPOXIDE CROSSLINKER AND POLYESTER HAVING TERMINAL TERTIARY CARBOXYL GROUPS FORMED BY REACTING PREPOLYESTER WITH COMPOUND HAVING TERTIARY CARBOXYL GROUP AND ANOTHER CARBOXYL GROUP OR HYDROXYL GROUP UCB, S.A. (BE) 2004-04-13 US disclosed
WO-2001070824-A2 STABLE INITIATOR SYSTEM JOHNSON & JOHNSON VISION CARE, INC. (US) 2001-09-27 WO disclosed
EP-0302516-B1 Optical article made of amorphous thermoplastic polyester resin MITSUBISHI RAYON CO (JP) 1993-12-15 EP disclosed
US-5075488-A Fungicides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-12-24 US disclosed
EP-0128006-B1 A SOIL-DISEASE-CONTROLLING AGENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-09-18 EP disclosed
US-4910291-A From aromatic diacid MITSUBISHI RAYON COMPANY LTD. (JP) 1990-03-20 US disclosed
EP-0302516-A2 Optical article made of amorphous thermoplastic polyester resin MITSUBISHI RAYON CO., LTD. (JP) 1989-02-08 EP disclosed
US-4709052-A FUNGICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-11-24 US disclosed
EP-0128006-A2 A soil-disease-controlling agent SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1984-12-12 EP disclosed
EP-0028430-B1 A PROCESS FOR THE ELECTROREDUCTIVE PREPARATION OF ORGANIC COMPOUNDS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1984-01-18 EP disclosed
EP-0028430-A1 A process for the electroreductive preparation of organic compounds SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1981-05-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10947231-B2 Processes for the preparation of substituted tetrahydro beta-carbolines TPH1, TPH2, HTR1B CYP2C19 69/4885HIF1A 2638/4885MAPT 1457/4885
US-20120136154-A1 PROCESSES FOR THE PREPARATION OF SUBSTITUTED TETRAHYDRO BETA-CARBOLINES TPH1, TPH2, HTR1B CYP2C19 59/4885HIF1A 2740/4885MAPT 1428/4885
US-20190135810-A1 PROCESSES FOR THE PREPARATION OF SUBSTITUTED TETRAHYDRO BETA-CARBOLINES TPH1, TPH2, HTR1B CYP2C19 69/4885HIF1A 2638/4885MAPT 1457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.